Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsFOR RX COMPOUNDINGGeneric

NEO-RX

NEOMYCIN SULFATE

Standard Dose
100%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEO-RX is listed in Drugs@FDA under application 061579 (ANDA).

Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE Form and strength POWDER;FOR RX COMPOUNDING - 100% Sponsor X GEN PHARMS Submission history Latest submission status date: 2001-04-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEO-RX is listed in Drugs@FDA under application 061579 (ANDA). Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE Form and strength POWDER;FOR RX COMPOUNDING - 100% Sponsor X GEN PHARMS Submission history Latest submission status date: 2001-04-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.